New Key Statistics Module, Z-Score and F-Score
NAS:LGND Key Ratios
| Market Cap $ M | 1,257.08 |
| Enterprise Value $ M | 1,092.93 |
| P/E(ttm) | 24.48 |
| PE Ratio without NRI | 20.60 |
| Forward PE Ratio | 26.53 |
| Price/Book | 1.78 |
| Price/Sales | 9.58 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 29.96 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 131.00 |
| EPS (TTM) $ | 2.90 |
| Beneish M-Score | -2.24 |
| 10-y EBITDA Growth Rate % | 25.40 |
| 5-y EBITDA Growth Rate % | -21.10 |
| y-y EBITDA Growth Rate % | 6.50 |
| EV-to-EBIT | 16.99 |
| EV-to-EBITDA | 10.93 |
| PEG | -- |
| Shares Outstanding M | 17.71 |
| Net Margin (%) | 39.72 |
| Operating Margin % | 7.48 |
| Pre-tax Margin (%) | 48.48 |
| Quick Ratio | 12.72 |
| Current Ratio | 14.15 |
| ROA % (ttm) | 6.71 |
| ROE % (ttm) | 7.96 |
| ROIC % (ttm) | 1.46 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.41 |
LGND Number of Guru Trades
LGND Volume of Guru Trades
Gurus Latest Trades with NAS:LGND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LGND is held by these investors
Total 2
Ligand Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LGND
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers